Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Author:

Nutman Amir,Lellouche Jonathan,Temkin Elizabeth,Daikos George,Skiada Anna,Durante-Mangoni Emanuele,Dishon-Benattar Yael,Bitterman Roni,Yahav Dafna,Daitch Vered,Bernardo Mariano,Iossa Domenico,Zusman Oren,Friberg Lena E.,Mouton Johan W.,Theuretzbacher Ursula,Leibovici Leonard,Paul Mical,Carmeli Yehuda,Paul Mical,Benattar Yael Dishon,Dickstein Yaakov,Bitterman Roni,Zayyad Hiba,Koppel Fidi,Zak-Doron Yael,Altunin Sergey,Andria Nizar,Neuberger Ami,Stern Anat,Petersiel Neta,Raines Marina,Karban Amir,Leibovici Leonard,Yahav Dafna,Eliakim-Raz Noa,Zusman Oren,Elbaz Michal,Atamna Heyam,Daitch Vered,Babich Tanya,Carmeli Yehuda,Nutman Amir,Adler Amos,Levi Inbar,Daikos George L.,Skiada Anna,Pavleas Ioannis,Antoniadou Anastasia,Kotsaki Antigoni,Durante-Mangoni Emanuele,Andini Roberto,Iossa Domenico,Bernardo Mariano,Cavezza Giusi,Bertolino Lorenzo,Giuffre Giuseppe,Giurazza Roberto,Cuccurullo Susanna,Galdo Maria,Murino Patrizia,Cristinziano Adriano,Corcione Antonio,Zampino Rosa,Pafundi Pia Clara,Mouton Johan,Friberg Lena,Kristoffersson Anders,Theuretzbacher Ursula

Funder

European Commission

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?;Vardakas;J Infect,2013

2. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia;Lemos;Clin Microbiol Infect,2014

3. Effectiveness and safety of colistin: prospective comparative cohort study;Paul;J Antimicrob Chemother,2010

4. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems;Zusman;Antimicrob Agents Chemother,2013

5. Combination therapy for carbapenem-resistant Gram-negative bacteria;Paul;J Antimicrob Chemother,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3